hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 6.70
+0.10 (1.52%)
At close: Mar 25, 2026
hVIVO Employees
hVIVO had 301 employees as of December 31, 2024. The number of employees increased by 27 or 9.85% compared to the previous year.
Employees
301
Change (1Y)
27
Growth (1Y)
9.85%
Revenue / Employee
180.96K GBP
Profits / Employee
17.55K GBP
Market Cap
45.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 301 | 27 | 9.85% |
| Dec 31, 2023 | 274 | 64 | 30.48% |
| Dec 31, 2022 | 210 | -8 | -3.67% |
| Dec 31, 2021 | 218 | 39 | 21.79% |
| Dec 31, 2020 | 179 | 47 | 35.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| 4basebio | 110 |
| Scancell Holdings | 60 |
| Arecor Therapeutics | 44 |
| Faron Pharmaceuticals Oy | 33 |
| Aptamer Group | 31 |
| Hemogenyx Pharmaceuticals | 16 |
| Poolbeg Pharma | 16 |
| Bioventix | 12 |
hVIVO News
- 5 months ago - Full Year 2024 hVIVO PLC Investor Presentation Transcript - GuruFocus
- 6 months ago - Half Year 2025 hVIVO PLC Earnings Presentation Transcript - GuruFocus
- 1 year ago - Cathal Friel to step down as HVivo chairman - Independent Ireland
- 1 year ago - ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting - Business Wire
- 1 year ago - Half Year 2024 hVIVO PLC Investor Presentation Transcript - GuruFocus
- 1 year ago - Earnings rise 68pc at pharmaceutical services firm Hvivo - Independent Ireland